Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sterile Concepts

This article was originally published in The Gray Sheet

Executive Summary

Marketer of sterile procedure trays is going public via a proposed offering of 5,443,000 shares of common stock at $18 per share, for a gross of $97.8 mil. Underwriters Wheat First Securities, Inc. and Salomon Brothers, Inc. have an option for an additional 800,000 shares to cover over-allotments. According to the terms of the offering, Sterile Concepts parent Carillon Enterprises, Inc., a wholly owned subsidiary of Carillon Health Systems, would divest all of its assets and liabilities other than shares of Sterile Concepts. CEI will change its name to Sterile Concepts Holdings, Inc., and will be listed on NASDAQ under the abbreviation "TRAY." SCI will pay Carillon a "selling stockholder dividend" of $9.5 mil.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel